학술논문

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in pregnancy.
Document Type
Article
Source
Journal of Oncology Pharmacy Practice. Apr2016, Vol. 22 Issue 2, p374-377. 4p.
Subject
*CANCER chemotherapy
*CHROMOSOMES
*LYMPHOBLASTIC leukemia
*EVALUATION of medical care
*IMATINIB
*PREGNANCY
Language
ISSN
1078-1552
Abstract
BCR-ABL inhibitors administered in conjunction with chemotherapy have significantly improved outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia but, for patients diagnosed during pregnancy, data on risks to the fetus are limited. We report a woman treated with chemotherapy and imatinib mesylate who delivered a healthy baby at 30 weeks, and we discuss available data. [ABSTRACT FROM AUTHOR]